Detalhe da pesquisa
1.
Pharmacokinetic-Pharmacodynamic Determinants of Clinical Outcomes for Rifampin-Resistant Tuberculosis: A Multisite Prospective Cohort Study.
Clin Infect Dis
; 76(3): 497-505, 2023 02 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35731948
2.
Gridlock from diagnosis to treatment of multidrug resistant tuberculosis (MDR-TB) in Tanzania: patients' perspectives from a focus group discussion.
BMC Public Health
; 20(1): 1667, 2020 Nov 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33160327
3.
Model-Based Relationship between the Molecular Bacterial Load Assay and Time to Positivity in Liquid Culture.
Antimicrob Agents Chemother
; 63(10)2019 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31358585
4.
Using WGS to identify antibiotic resistance genes and predict antimicrobial resistance phenotypes in MDR Acinetobacter baumannii in Tanzania.
J Antimicrob Chemother
; 74(6): 1484-1493, 2019 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30843063
5.
Effect of diabetes mellitus on TB drug concentrations in Tanzanian patients.
J Antimicrob Chemother
; 74(12): 3537-3545, 2019 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31651031
6.
Underestimated pyrazinamide resistance may compromise outcomes of pyrazinamide containing regimens for treatment of drug susceptible and multi-drug-resistant tuberculosis in Tanzania.
BMC Infect Dis
; 19(1): 129, 2019 Feb 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-30732572
7.
Gridlock from diagnosis to treatment of multidrug-resistant tuberculosis in Tanzania: low accessibility of molecular diagnostic services and lack of healthcare worker empowerment in 28 districts of 5 high burden TB regions with mixed methods evaluation.
BMC Public Health
; 19(1): 395, 2019 Apr 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-30971228
8.
The Potential for Treatment Shortening With Higher Rifampicin Doses: Relating Drug Exposure to Treatment Response in Patients With Pulmonary Tuberculosis.
Clin Infect Dis
; 67(1): 34-41, 2018 06 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-29917079
9.
Molecular epidemiology of virulence and antimicrobial resistance determinants in Klebsiella pneumoniae from hospitalised patients in Kilimanjaro, Tanzania.
Eur J Clin Microbiol Infect Dis
; 37(10): 1901-1914, 2018 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-30030694
10.
A new trial design to accelerate tuberculosis drug development: the Phase IIC Selection Trial with Extended Post-treatment follow-up (STEP).
BMC Med
; 14: 51, 2016 Mar 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-27004726
11.
Feasibility of Real Time Medication Monitoring Among HIV Infected and TB Patients in a Resource-Limited Setting.
AIDS Behav
; 20(5): 1097-107, 2016 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-26604004
12.
Sensititre MycoTB plate compared to Bactec MGIT 960 for first- and second-line antituberculosis drug susceptibility testing in Tanzania: a call to operationalize MICs.
Antimicrob Agents Chemother
; 59(11): 7104-8, 2015 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-26303804
13.
Pharmacological interactions between rifampicin and antiretroviral drugs: challenges and research priorities for resource-limited settings.
Ther Drug Monit
; 37(1): 22-32, 2015 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-24943062
14.
Plasma drug activity in patients on treatment for multidrug-resistant tuberculosis.
Antimicrob Agents Chemother
; 58(2): 782-8, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-24247125
15.
A randomized controlled trial of standard versus intensified tuberculosis diagnostics on treatment decisions by physicians in Northern Tanzania.
BMC Infect Dis
; 14: 89, 2014 Feb 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-24552306
16.
Pharmacokinetics of first-line tuberculosis drugs in Tanzanian patients.
Antimicrob Agents Chemother
; 57(7): 3208-13, 2013 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-23629715
17.
Application of quantitative second-line drug susceptibility testing at a multidrug-resistant tuberculosis hospital in Tanzania.
BMC Infect Dis
; 13: 432, 2013 Sep 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-24034230
18.
Prevalence and risk factors for infection of bovine tuberculosis in indigenous cattle in the Serengeti ecosystem, Tanzania.
BMC Vet Res
; 9: 267, 2013 Dec 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-24377705
19.
Protocol for a feasibility randomized controlled trial to evaluate the efficacy, safety and tolerability of N-acetylcysteine in reducing adverse drug reactions among adults treated for multidrug-resistant tuberculosis in Tanzania.
Pilot Feasibility Stud
; 9(1): 55, 2023 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37005695
20.
Effect of seven anti-tuberculosis treatment regimens on sputum microbiome: a retrospective analysis of the HIGHRIF study 2 and PanACEA MAMS-TB clinical trials.
Lancet Microbe
; 4(11): e913-e922, 2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37832571